Abstract
Cryptococcus is an important opportunistic, pathogenic fungus that can infect both immunocompromised and immunocompetent individuals. The infection always involves the central nervous system (CNS), presenting as meningitis or meningoencephalitis. Cryptococcal infections of the lung also occur; however, these infections have been largely ignored because of the atypical clinical symptoms associated with them. Therefore, it is necessary to study Cryptococcus infections of the lung to gain a better understanding of the epidemiology, treatment and diagnosis of pulmonary cryptococcosis.
Keywords: Cryptococcus neoformans, Cryptococcus gattii, pneumonia.
Current Respiratory Medicine Reviews
Title:Pulmonary Cryptococcocal Infection
Volume: 8 Issue: 5
Author(s): Meng Li and Wanqing Liao
Affiliation:
Keywords: Cryptococcus neoformans, Cryptococcus gattii, pneumonia.
Abstract: Cryptococcus is an important opportunistic, pathogenic fungus that can infect both immunocompromised and immunocompetent individuals. The infection always involves the central nervous system (CNS), presenting as meningitis or meningoencephalitis. Cryptococcal infections of the lung also occur; however, these infections have been largely ignored because of the atypical clinical symptoms associated with them. Therefore, it is necessary to study Cryptococcus infections of the lung to gain a better understanding of the epidemiology, treatment and diagnosis of pulmonary cryptococcosis.
Export Options
About this article
Cite this article as:
Li Meng and Liao Wanqing, Pulmonary Cryptococcocal Infection, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832511
DOI https://dx.doi.org/10.2174/157339812803832511 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Virus Diagnostics on Microarrays
Current Pharmaceutical Biotechnology Lymphocytic Choriomeningitis Virus Infection: Neglected Teratogenic Zoonosis
Current Women`s Health Reviews Biochemical Markers in CSF of ALS Patients
Current Medicinal Chemistry Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) Quantitative and Mechanistic Studies of Aβ Immunotherapy
CNS & Neurological Disorders - Drug Targets DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome
Current Drug Safety Momordica balsamina: A Medicinal and Neutraceutical Plant for Health Care Management
Current Pharmaceutical Biotechnology The Prognosis of Pediatric AIDS in Serbia
Current HIV Research Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
Current Pharmaceutical Design The Amyloid β-Protein Precursor and Alzheimers Disease. Therapeutic Approaches
Current Medicinal Chemistry - Central Nervous System Agents Challenges in Chagas Disease Drug Discovery: A Review
Current Medicinal Chemistry Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
Current Medicinal Chemistry Changing the Course of Alzheimers Disease: Emerging Disease Modifying Therapies
Current Psychiatry Reviews Adenovirus Meningoencephalitis and Neurocysticercosis Co-infection: First Case from India
Infectious Disorders - Drug Targets Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy
Current Topics in Medicinal Chemistry Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
Current Alzheimer Research Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS
Current Pharmaceutical Design New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease
Current Pharmaceutical Biotechnology